HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation.
Authors
Myant, KCammareri, P
Hodder, M
Wills, J
Von Kriegsheim, A
Győrffy, B
Rashid, M
Polo, S
Maspero, E
Vaughan, Lynsey
Gurung, B
Barry, E
Malliri, Angeliki
Camargo, F
Adams, D
Iavarone, A
Lasorella, A
Sansom, O
Affiliation
Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow, UKIssue Date
2017-02
Metadata
Show full item recordAbstract
Cancer genome sequencing projects have identified hundreds of genetic alterations, often at low frequencies, raising questions as to their functional relevance. One exemplar gene is HUWE1, which has been found to be mutated in numerous studies. However, due to the large size of this gene and a lack of functional analysis of identified mutations, their significance to carcinogenesis is unclear. To determine the importance of HUWE1, we chose to examine its function in colorectal cancer, where it is mutated in up to 15 per cent of tumours. Modelling of identified mutations showed that they inactivate the E3 ubiquitin ligase activity of HUWE1. Genetic deletion of Huwe1 rapidly accelerated tumourigenic in mice carrying loss of the intestinal tumour suppressor gene Apc, with a dramatic increase in tumour initiation. Mechanistically, this phenotype was driven by increased MYC and rapid DNA damage accumulation leading to loss of the second copy of Apc The increased levels of DNA damage sensitised Huwe1-deficient tumours to DNA-damaging agents and to deletion of the anti-apoptotic protein MCL1. Taken together, these data identify HUWE1 as a bona fide tumour suppressor gene in the intestinal epithelium and suggest a potential vulnerability of HUWE1-mutated tumours to DNA-damaging agents and inhibitors of anti-apoptotic proteins.Citation
HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation. 2017, 9 (2):181-197 EMBO Mol MedJournal
EMBO Molecular MedicineDOI
10.15252/emmm.201606684PubMed ID
28003334Type
ArticleLanguage
enISSN
1757-4684ae974a485f413a2113503eed53cd6c53
10.15252/emmm.201606684
Scopus Count
Collections
Related articles
- Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models.
- Authors: Kunz V, Bommert KS, Kruk J, Schwinning D, Chatterjee M, Stühmer T, Bargou R, Bommert K
- Issue date: 2020 Oct 28
- The MULE/HUWE1 E3 ubiquitin ligase is a tumor suppressor.
- Issue date: 2013 Jul
- Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
- Authors: Bonazzoli E, Bellone S, Zammataro L, Gnutti B, Guglielmi A, Pelligra S, Nagarkatti N, Manara P, Tymon-Rosario J, Zeybek B, Altwerger G, Menderes G, Han C, Ratner E, Silasi DA, Huang GS, Andikyan V, Azodi M, Schwartz PE, Santin AD
- Issue date: 2020 Sep
- HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
- Authors: Qu H, Liu H, Jin Y, Cui Z, Han G
- Issue date: 2018 Oct
- The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
- Authors: Crawford LJ, Campbell DC, Morgan JJ, Lawson MA, Down JM, Chauhan D, McAvera RM, Morris TC, Hamilton C, Krishnan A, Rajalingam K, Chantry AD, Irvine AE
- Issue date: 2020 Jul